UnitedHealth's Stealth Stake Sales to Meet Earnings Targets

Stealth Stake Sales to Boost Profits

• 🤫 UnitedHealth Group quietly sold stakes in its business units to private equity firms like Warburg Pincus and KKR & Co. near the end of last year.
• 📈 These discreet transactions, structured to potentially require UnitedHealth to buy back stakes at a higher price later, helped book an additional $3.3 billion in annual profit.
• 🎯 The deals were notably completed by December 31st and kept from public view, suggesting a focus on meeting earnings targets.

Impact on Financial Reporting

• 📊 The $3.3 billion gain was recognized as part of operating earnings and adjusted earnings per share, key profit measures.
• ⚠️ Without these gains, UnitedHealth would have missed Wall Street estimates for the first time in over 15 years.
• 📉 The company also excluded a $7.1 billion loss from the sale of its Brazil business from these adjusted measures, a move deemed "unusual" but permissible under US accounting rules.

Analyst Concerns and Business Model

• 🧐 An analyst expressed concern that manufacturing earnings through asset sales could be masking underlying operational weaknesses.
• 🏢 While disclosed in footnotes, the lack of detail about the specific assets sold clouds the ability to assess the business's true performance.
• 🗣️ Sources indicate a company culture with pressure to meet targets every quarter.

Broader Company Challenges

• 📉 Despite its size, UnitedHealth's stock has fallen 40%, reflecting investor concerns.
• 🚨 Recent issues include the murder of an executive, a Wall Street Journal investigation into potential Medicare fraud (which the company denies), and the first earnings miss in over 60 quarters.
• 💼 The company ousted its CEO and withdrew its 2025 forecast due to higher-than-expected costs in Medicare Advantage, contributing to uncertainty about the company's future narrative.